Details of Host Protein-DME Interaction (HOSPPI)
General Information of Drug-Metabolizing Enzyme (DME ID: DME0299) | |||||
---|---|---|---|---|---|
DME Name | Aminomuconic semialdehyde dehydrogenase (ALDH12), Homo sapiens | DME Info | |||
UniProt ID | |||||
EC Number | EC: 1.2.1.3 (Click to Show/Hide the Complete EC Tree) | ||||
Lineage | Species: Homo sapiens (Click to Show/Hide the Complete Species Lineage) | ||||
Interactome |
Disease Specific Interactions between Host Protein and DME (HOSPPI) | |||||
---|---|---|---|---|---|
ICD Disease Classification 02 Neoplasms | |||||
ICD-11: 2A00 Brain cancer | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
DNA methylation | |||||
DNA methyltransferase (DNMT) | Brain neuroblastoma | Moderate hypomethylation | |||
Interaction Name | DNMT-ALDH12 interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Moderate hypomethylation p-value: 1.90E-17; delta-beta: -2.65E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to moderatly hypo-methylate the ALDH12 gene, which leads to a moderatly increased expression of the drug-metabolizing enzyme Aminomuconic semialdehyde dehydrogenase. As a result, the interaction between DNMT and ALDH12 can moderatly affect the drug-metabolizing process of Aminomuconic semialdehyde dehydrogenase. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
ICD-11: 2B30 Lymphoma | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
DNA methylation | |||||
DNA methyltransferase (DNMT) | Lymphoma | Significant hypomethylation | |||
Interaction Name | DNMT-ALDH12 interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypomethylation p-value: 3.94E-07; delta-beta: -3.34E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the ALDH12 gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Aminomuconic semialdehyde dehydrogenase. As a result, the interaction between DNMT and ALDH12 can significantly affect the drug-metabolizing process of Aminomuconic semialdehyde dehydrogenase. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.